TIME TO RESPONSE FOR CLINICAL AND PATIENT-REPORTED OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH TOFACITINIB, ADALIMUMAB OR PLACEBO

被引：0
|
作者：
Gladman, D. D.
Coates, L. C.
Wu, J.
Fallon, L.
Hsu, M. A.
Bushmakin, A. G.
Bacci, E.
Cappelleri, J. C.
Helliwell, P.
机构：
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.994
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0774
引用
收藏
页码：1681 / 1681
页数：1
相关论文
共 50 条
  • [21] Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis: Results from two phase 3 studies
    Strand, Vibeke
    de Vlam, Kurt
    Covarrubias-Cobos, Jose
    Mease, Philip
    Gladman, Dafna
    Hendrikx, Thijs
    Graham, Daniela
    Wu, Joseph
    Chen, Linda
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB109 - AB109
  • [22] EFFECT OF TOFACITINIB ON PATIENT-REPORTED OUTCOMES IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM TWO PHASE 3 STUDIES
    Strand, V.
    de Vlam, K.
    Covarrubias-Cobos, J. A.
    Mease, P. J.
    Gladman, D. D.
    Hendrikx, T.
    Kudlacz, E.
    Graham, D.
    Wu, J.
    Chen, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1335 - 1336
  • [23] Effect of Tofacitinib on Patient-Reported Outcomes in Patients with Active Psoriatic Arthritis: Results from 2 Phase 3 Studies
    Strand, Vibeke
    de Vlam, Kurt
    Covarrubias-Cobos, Jose A.
    Mease, Philip J.
    Gladman, Dafna D.
    Hendrikx, Thijs
    Kudlacz, Elizabeth
    Graham, Daniela
    Wu, Joseph
    Cappelleri, Joseph C.
    Hsu, Ming-Ann
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [24] TOFACITINIB IMPROVES DISEASE ACTIVITY AND PATIENT-REPORTED OUTCOMES (PROS) IN PATIENTS (PTS) WITH ACTIVE PSORIATIC ARTHRITIS (PSA) IN REAL CLINICAL PRACTICE.
    Korotaeva, T.
    Vorobyova, L.
    Loginova, E.
    Gubar, E.
    Korsakova, Y.
    Glukhova, S.
    Karpova, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1725 - 1725
  • [25] PATIENT-REPORTED OUTCOMES AMONG TREATED RHEUMATOID ARTHRITIS PATIENTS
    Feinberg, B. A.
    Olson, T.
    Burruss, R. A.
    Garofalo, D. F.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A237 - A237
  • [26] ASSOCIATION BETWEEN PATIENT-REPORTED OUTCOMES AND DISEASE ACTIVITY IN BIMEKIZUMAB-TREATED PATIENTS WITH PSORIATIC ARTHRITIS
    Gossec, L.
    Mease, P. J.
    Gottlieb, A. B.
    Ogdie, A.
    Assudani, D.
    Coarse, J.
    Ink, B.
    Coates, L. C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1683 - 1683
  • [27] Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial
    Strand, Vibeke
    Mysler, Eduardo
    Moots, Robert J.
    Wallenstein, Gene, V
    DeMasi, Ryan
    Gruben, David
    Soma, Koshika
    Iikuni, Noriko
    Smolen, Josef S.
    Fleischmann, Roy
    [J]. RMD OPEN, 2019, 5 (02):
  • [28] Critical importance of patient-reported outcomes for a comprehensive assessment of psoriatic arthritis patients
    Lo Monaco, Marika
    Bocchio, Raffaella Mallaci
    Natoli, Giuseppe
    Giardina, Annarita
    Cangemi, Ignazio
    Scibetta, Salvatore
    Argano, Christiano
    Corrao, Salvatore
    [J]. FRONTIERS IN MEDICINE, 2024, 10
  • [29] Improved Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Who Failed Adalimumab or Placebo Treatment and Were Rescued with Baricitinib
    Fautrel, Bruno
    Taylor, Peter C.
    Michaud, Kaleb
    Patel, Himanshu
    Zhu, Baojin
    Gaich, Carol L.
    Guo, Jiaying
    Quebe, Amanda
    Tanaka, Yoshiya
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [30] Interpreting the efficacy of secukinumab on patient-reported outcomes in psoriatic arthritis
    Gossec, Laure
    [J]. LANCET RHEUMATOLOGY, 2022, 4 (03): : E159 - E160
12345